Global Anticancer Drugs Market 2025 by Company, Regions, Type and Application, Forecast to 2031
According to our (Global Info Research) latest study, the global Anticancer Drugs market size was valued at US$ 212060 million in 2024 and is forecast to a readjusted size of USD 436720 million by 2031 with a CAGR of 11.0% during review period.
Anticancer drugs are medications used to treat cancer by targeting and killing cancer cells or inhibiting their growth. Anticancer drugs are medications specifically designed to combat cancer by either inhibiting the growth of cancer cells or inducing their death. These drugs operate through various mechanisms, such as disrupting the cell cycle, interfering with specific signaling pathways crucial for cancer cell survival, or targeting the blood vessels that support tumor growth. Anticancer drugs encompass a diverse range of classes, including cytotoxic drugs, targeted therapies, hormone therapies, immunotherapies, and angiogenesis inhibitors. The selection of these drugs depends on the type of cancer, its stage, and individual patient characteristics. While these medications play a crucial role in cancer treatment, they may also have side effects due to their impact on rapidly dividing normal cells.
Global key players of Anticancer Drugs include Merck & Co, Bristol-Myers Squibb, Roche, Novartis, Johnson & Johnson, etc. The top five players hold a share over 55%. North America is the largest market, and has a share about 55%, followed by Asia-Pacific and Europe with share 21% and 19%, separately. In terms of product type, Targeted Therapy is the largest segment, occupied for a share of 58%. In terms of application, Blood-related Cancer has a share about 23 percent.
This report is a detailed and comprehensive analysis for global Anticancer Drugs market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Anticancer Drugs market size and forecasts, in consumption value ($ Million), 2020-2031
Global Anticancer Drugs market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Anticancer Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Anticancer Drugs market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Anticancer Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Anticancer Drugs market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AbbVie, Johnson & Johnson, Novartis, Gilead Sciences, Roche, Bristol-Myers Squibb, Amgen, AstraZeneca, Merck & Co, Takeda, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Anticancer Drugs market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Anticancer Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Anticancer Drugs, with revenue, gross margin, and global market share of Anticancer Drugs from 2020 to 2025.
Chapter 3, the Anticancer Drugs competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Anticancer Drugs market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Anticancer Drugs.
Chapter 13, to describe Anticancer Drugs research findings and conclusion.
Anticancer drugs are medications used to treat cancer by targeting and killing cancer cells or inhibiting their growth. Anticancer drugs are medications specifically designed to combat cancer by either inhibiting the growth of cancer cells or inducing their death. These drugs operate through various mechanisms, such as disrupting the cell cycle, interfering with specific signaling pathways crucial for cancer cell survival, or targeting the blood vessels that support tumor growth. Anticancer drugs encompass a diverse range of classes, including cytotoxic drugs, targeted therapies, hormone therapies, immunotherapies, and angiogenesis inhibitors. The selection of these drugs depends on the type of cancer, its stage, and individual patient characteristics. While these medications play a crucial role in cancer treatment, they may also have side effects due to their impact on rapidly dividing normal cells.
Global key players of Anticancer Drugs include Merck & Co, Bristol-Myers Squibb, Roche, Novartis, Johnson & Johnson, etc. The top five players hold a share over 55%. North America is the largest market, and has a share about 55%, followed by Asia-Pacific and Europe with share 21% and 19%, separately. In terms of product type, Targeted Therapy is the largest segment, occupied for a share of 58%. In terms of application, Blood-related Cancer has a share about 23 percent.
This report is a detailed and comprehensive analysis for global Anticancer Drugs market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Anticancer Drugs market size and forecasts, in consumption value ($ Million), 2020-2031
Global Anticancer Drugs market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Anticancer Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Anticancer Drugs market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Anticancer Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Anticancer Drugs market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AbbVie, Johnson & Johnson, Novartis, Gilead Sciences, Roche, Bristol-Myers Squibb, Amgen, AstraZeneca, Merck & Co, Takeda, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Anticancer Drugs market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Cancer Immunotherapy
- Targeted Therapy
- Chemotherapy
- Other
- Lung Cancer
- Breast Cancer
- Prostate Cancer
- Blood-related Cancer
- Other
- AbbVie
- Johnson & Johnson
- Novartis
- Gilead Sciences
- Roche
- Bristol-Myers Squibb
- Amgen
- AstraZeneca
- Merck & Co
- Takeda
- Merck KGaA
- Seagen
- Eli Lilly
- Ono Pharmaceutical
- Pfizer
- GSK
- Exelixis
- Regeneron
- Innovent
- Hengrui Medicine
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Anticancer Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Anticancer Drugs, with revenue, gross margin, and global market share of Anticancer Drugs from 2020 to 2025.
Chapter 3, the Anticancer Drugs competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Anticancer Drugs market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Anticancer Drugs.
Chapter 13, to describe Anticancer Drugs research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Anticancer Drugs by Type
1.3.1 Overview: Global Anticancer Drugs Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Anticancer Drugs Consumption Value Market Share by Type in 2024
1.3.3 Cancer Immunotherapy
1.3.4 Targeted Therapy
1.3.5 Chemotherapy
1.3.6 Other
1.4 Global Anticancer Drugs Market by Application
1.4.1 Overview: Global Anticancer Drugs Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Lung Cancer
1.4.3 Breast Cancer
1.4.4 Prostate Cancer
1.4.5 Blood-related Cancer
1.4.6 Other
1.5 Global Anticancer Drugs Market Size & Forecast
1.6 Global Anticancer Drugs Market Size and Forecast by Region
1.6.1 Global Anticancer Drugs Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Anticancer Drugs Market Size by Region, (2020-2031)
1.6.3 North America Anticancer Drugs Market Size and Prospect (2020-2031)
1.6.4 Europe Anticancer Drugs Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Anticancer Drugs Market Size and Prospect (2020-2031)
1.6.6 South America Anticancer Drugs Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Anticancer Drugs Market Size and Prospect (2020-2031)
2 COMPANY PROFILES
2.1 AbbVie
2.1.1 AbbVie Details
2.1.2 AbbVie Major Business
2.1.3 AbbVie Anticancer Drugs Product and Solutions
2.1.4 AbbVie Anticancer Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 AbbVie Recent Developments and Future Plans
2.2 Johnson & Johnson
2.2.1 Johnson & Johnson Details
2.2.2 Johnson & Johnson Major Business
2.2.3 Johnson & Johnson Anticancer Drugs Product and Solutions
2.2.4 Johnson & Johnson Anticancer Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Johnson & Johnson Recent Developments and Future Plans
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Anticancer Drugs Product and Solutions
2.3.4 Novartis Anticancer Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Novartis Recent Developments and Future Plans
2.4 Gilead Sciences
2.4.1 Gilead Sciences Details
2.4.2 Gilead Sciences Major Business
2.4.3 Gilead Sciences Anticancer Drugs Product and Solutions
2.4.4 Gilead Sciences Anticancer Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Gilead Sciences Recent Developments and Future Plans
2.5 Roche
2.5.1 Roche Details
2.5.2 Roche Major Business
2.5.3 Roche Anticancer Drugs Product and Solutions
2.5.4 Roche Anticancer Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Roche Recent Developments and Future Plans
2.6 Bristol-Myers Squibb
2.6.1 Bristol-Myers Squibb Details
2.6.2 Bristol-Myers Squibb Major Business
2.6.3 Bristol-Myers Squibb Anticancer Drugs Product and Solutions
2.6.4 Bristol-Myers Squibb Anticancer Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Bristol-Myers Squibb Recent Developments and Future Plans
2.7 Amgen
2.7.1 Amgen Details
2.7.2 Amgen Major Business
2.7.3 Amgen Anticancer Drugs Product and Solutions
2.7.4 Amgen Anticancer Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Amgen Recent Developments and Future Plans
2.8 AstraZeneca
2.8.1 AstraZeneca Details
2.8.2 AstraZeneca Major Business
2.8.3 AstraZeneca Anticancer Drugs Product and Solutions
2.8.4 AstraZeneca Anticancer Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 AstraZeneca Recent Developments and Future Plans
2.9 Merck & Co
2.9.1 Merck & Co Details
2.9.2 Merck & Co Major Business
2.9.3 Merck & Co Anticancer Drugs Product and Solutions
2.9.4 Merck & Co Anticancer Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Merck & Co Recent Developments and Future Plans
2.10 Takeda
2.10.1 Takeda Details
2.10.2 Takeda Major Business
2.10.3 Takeda Anticancer Drugs Product and Solutions
2.10.4 Takeda Anticancer Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Takeda Recent Developments and Future Plans
2.11 Merck KGaA
2.11.1 Merck KGaA Details
2.11.2 Merck KGaA Major Business
2.11.3 Merck KGaA Anticancer Drugs Product and Solutions
2.11.4 Merck KGaA Anticancer Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Merck KGaA Recent Developments and Future Plans
2.12 Seagen
2.12.1 Seagen Details
2.12.2 Seagen Major Business
2.12.3 Seagen Anticancer Drugs Product and Solutions
2.12.4 Seagen Anticancer Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Seagen Recent Developments and Future Plans
2.13 Eli Lilly
2.13.1 Eli Lilly Details
2.13.2 Eli Lilly Major Business
2.13.3 Eli Lilly Anticancer Drugs Product and Solutions
2.13.4 Eli Lilly Anticancer Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Eli Lilly Recent Developments and Future Plans
2.14 Ono Pharmaceutical
2.14.1 Ono Pharmaceutical Details
2.14.2 Ono Pharmaceutical Major Business
2.14.3 Ono Pharmaceutical Anticancer Drugs Product and Solutions
2.14.4 Ono Pharmaceutical Anticancer Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 Ono Pharmaceutical Recent Developments and Future Plans
2.15 Pfizer
2.15.1 Pfizer Details
2.15.2 Pfizer Major Business
2.15.3 Pfizer Anticancer Drugs Product and Solutions
2.15.4 Pfizer Anticancer Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 Pfizer Recent Developments and Future Plans
2.16 GSK
2.16.1 GSK Details
2.16.2 GSK Major Business
2.16.3 GSK Anticancer Drugs Product and Solutions
2.16.4 GSK Anticancer Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.16.5 GSK Recent Developments and Future Plans
2.17 Exelixis
2.17.1 Exelixis Details
2.17.2 Exelixis Major Business
2.17.3 Exelixis Anticancer Drugs Product and Solutions
2.17.4 Exelixis Anticancer Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.17.5 Exelixis Recent Developments and Future Plans
2.18 Regeneron
2.18.1 Regeneron Details
2.18.2 Regeneron Major Business
2.18.3 Regeneron Anticancer Drugs Product and Solutions
2.18.4 Regeneron Anticancer Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.18.5 Regeneron Recent Developments and Future Plans
2.19 Innovent
2.19.1 Innovent Details
2.19.2 Innovent Major Business
2.19.3 Innovent Anticancer Drugs Product and Solutions
2.19.4 Innovent Anticancer Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.19.5 Innovent Recent Developments and Future Plans
2.20 Hengrui Medicine
2.20.1 Hengrui Medicine Details
2.20.2 Hengrui Medicine Major Business
2.20.3 Hengrui Medicine Anticancer Drugs Product and Solutions
2.20.4 Hengrui Medicine Anticancer Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.20.5 Hengrui Medicine Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Anticancer Drugs Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Anticancer Drugs by Company Revenue
3.2.2 Top 3 Anticancer Drugs Players Market Share in 2024
3.2.3 Top 6 Anticancer Drugs Players Market Share in 2024
3.3 Anticancer Drugs Market: Overall Company Footprint Analysis
3.3.1 Anticancer Drugs Market: Region Footprint
3.3.2 Anticancer Drugs Market: Company Product Type Footprint
3.3.3 Anticancer Drugs Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Anticancer Drugs Consumption Value and Market Share by Type (2020-2025)
4.2 Global Anticancer Drugs Market Forecast by Type (2026-2031)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Anticancer Drugs Consumption Value Market Share by Application (2020-2025)
5.2 Global Anticancer Drugs Market Forecast by Application (2026-2031)
6 NORTH AMERICA
6.1 North America Anticancer Drugs Consumption Value by Type (2020-2031)
6.2 North America Anticancer Drugs Market Size by Application (2020-2031)
6.3 North America Anticancer Drugs Market Size by Country
6.3.1 North America Anticancer Drugs Consumption Value by Country (2020-2031)
6.3.2 United States Anticancer Drugs Market Size and Forecast (2020-2031)
6.3.3 Canada Anticancer Drugs Market Size and Forecast (2020-2031)
6.3.4 Mexico Anticancer Drugs Market Size and Forecast (2020-2031)
7 EUROPE
7.1 Europe Anticancer Drugs Consumption Value by Type (2020-2031)
7.2 Europe Anticancer Drugs Consumption Value by Application (2020-2031)
7.3 Europe Anticancer Drugs Market Size by Country
7.3.1 Europe Anticancer Drugs Consumption Value by Country (2020-2031)
7.3.2 Germany Anticancer Drugs Market Size and Forecast (2020-2031)
7.3.3 France Anticancer Drugs Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Anticancer Drugs Market Size and Forecast (2020-2031)
7.3.5 Russia Anticancer Drugs Market Size and Forecast (2020-2031)
7.3.6 Italy Anticancer Drugs Market Size and Forecast (2020-2031)
8 ASIA-PACIFIC
8.1 Asia-Pacific Anticancer Drugs Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Anticancer Drugs Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Anticancer Drugs Market Size by Region
8.3.1 Asia-Pacific Anticancer Drugs Consumption Value by Region (2020-2031)
8.3.2 China Anticancer Drugs Market Size and Forecast (2020-2031)
8.3.3 Japan Anticancer Drugs Market Size and Forecast (2020-2031)
8.3.4 South Korea Anticancer Drugs Market Size and Forecast (2020-2031)
8.3.5 India Anticancer Drugs Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Anticancer Drugs Market Size and Forecast (2020-2031)
8.3.7 Australia Anticancer Drugs Market Size and Forecast (2020-2031)
9 SOUTH AMERICA
9.1 South America Anticancer Drugs Consumption Value by Type (2020-2031)
9.2 South America Anticancer Drugs Consumption Value by Application (2020-2031)
9.3 South America Anticancer Drugs Market Size by Country
9.3.1 South America Anticancer Drugs Consumption Value by Country (2020-2031)
9.3.2 Brazil Anticancer Drugs Market Size and Forecast (2020-2031)
9.3.3 Argentina Anticancer Drugs Market Size and Forecast (2020-2031)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Anticancer Drugs Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Anticancer Drugs Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Anticancer Drugs Market Size by Country
10.3.1 Middle East & Africa Anticancer Drugs Consumption Value by Country (2020-2031)
10.3.2 Turkey Anticancer Drugs Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Anticancer Drugs Market Size and Forecast (2020-2031)
10.3.4 UAE Anticancer Drugs Market Size and Forecast (2020-2031)
11 MARKET DYNAMICS
11.1 Anticancer Drugs Market Drivers
11.2 Anticancer Drugs Market Restraints
11.3 Anticancer Drugs Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Anticancer Drugs Industry Chain
12.2 Anticancer Drugs Upstream Analysis
12.3 Anticancer Drugs Midstream Analysis
12.4 Anticancer Drugs Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Anticancer Drugs by Type
1.3.1 Overview: Global Anticancer Drugs Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Anticancer Drugs Consumption Value Market Share by Type in 2024
1.3.3 Cancer Immunotherapy
1.3.4 Targeted Therapy
1.3.5 Chemotherapy
1.3.6 Other
1.4 Global Anticancer Drugs Market by Application
1.4.1 Overview: Global Anticancer Drugs Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Lung Cancer
1.4.3 Breast Cancer
1.4.4 Prostate Cancer
1.4.5 Blood-related Cancer
1.4.6 Other
1.5 Global Anticancer Drugs Market Size & Forecast
1.6 Global Anticancer Drugs Market Size and Forecast by Region
1.6.1 Global Anticancer Drugs Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Anticancer Drugs Market Size by Region, (2020-2031)
1.6.3 North America Anticancer Drugs Market Size and Prospect (2020-2031)
1.6.4 Europe Anticancer Drugs Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Anticancer Drugs Market Size and Prospect (2020-2031)
1.6.6 South America Anticancer Drugs Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Anticancer Drugs Market Size and Prospect (2020-2031)
2 COMPANY PROFILES
2.1 AbbVie
2.1.1 AbbVie Details
2.1.2 AbbVie Major Business
2.1.3 AbbVie Anticancer Drugs Product and Solutions
2.1.4 AbbVie Anticancer Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 AbbVie Recent Developments and Future Plans
2.2 Johnson & Johnson
2.2.1 Johnson & Johnson Details
2.2.2 Johnson & Johnson Major Business
2.2.3 Johnson & Johnson Anticancer Drugs Product and Solutions
2.2.4 Johnson & Johnson Anticancer Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Johnson & Johnson Recent Developments and Future Plans
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Anticancer Drugs Product and Solutions
2.3.4 Novartis Anticancer Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Novartis Recent Developments and Future Plans
2.4 Gilead Sciences
2.4.1 Gilead Sciences Details
2.4.2 Gilead Sciences Major Business
2.4.3 Gilead Sciences Anticancer Drugs Product and Solutions
2.4.4 Gilead Sciences Anticancer Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Gilead Sciences Recent Developments and Future Plans
2.5 Roche
2.5.1 Roche Details
2.5.2 Roche Major Business
2.5.3 Roche Anticancer Drugs Product and Solutions
2.5.4 Roche Anticancer Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Roche Recent Developments and Future Plans
2.6 Bristol-Myers Squibb
2.6.1 Bristol-Myers Squibb Details
2.6.2 Bristol-Myers Squibb Major Business
2.6.3 Bristol-Myers Squibb Anticancer Drugs Product and Solutions
2.6.4 Bristol-Myers Squibb Anticancer Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Bristol-Myers Squibb Recent Developments and Future Plans
2.7 Amgen
2.7.1 Amgen Details
2.7.2 Amgen Major Business
2.7.3 Amgen Anticancer Drugs Product and Solutions
2.7.4 Amgen Anticancer Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Amgen Recent Developments and Future Plans
2.8 AstraZeneca
2.8.1 AstraZeneca Details
2.8.2 AstraZeneca Major Business
2.8.3 AstraZeneca Anticancer Drugs Product and Solutions
2.8.4 AstraZeneca Anticancer Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 AstraZeneca Recent Developments and Future Plans
2.9 Merck & Co
2.9.1 Merck & Co Details
2.9.2 Merck & Co Major Business
2.9.3 Merck & Co Anticancer Drugs Product and Solutions
2.9.4 Merck & Co Anticancer Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Merck & Co Recent Developments and Future Plans
2.10 Takeda
2.10.1 Takeda Details
2.10.2 Takeda Major Business
2.10.3 Takeda Anticancer Drugs Product and Solutions
2.10.4 Takeda Anticancer Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Takeda Recent Developments and Future Plans
2.11 Merck KGaA
2.11.1 Merck KGaA Details
2.11.2 Merck KGaA Major Business
2.11.3 Merck KGaA Anticancer Drugs Product and Solutions
2.11.4 Merck KGaA Anticancer Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Merck KGaA Recent Developments and Future Plans
2.12 Seagen
2.12.1 Seagen Details
2.12.2 Seagen Major Business
2.12.3 Seagen Anticancer Drugs Product and Solutions
2.12.4 Seagen Anticancer Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Seagen Recent Developments and Future Plans
2.13 Eli Lilly
2.13.1 Eli Lilly Details
2.13.2 Eli Lilly Major Business
2.13.3 Eli Lilly Anticancer Drugs Product and Solutions
2.13.4 Eli Lilly Anticancer Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Eli Lilly Recent Developments and Future Plans
2.14 Ono Pharmaceutical
2.14.1 Ono Pharmaceutical Details
2.14.2 Ono Pharmaceutical Major Business
2.14.3 Ono Pharmaceutical Anticancer Drugs Product and Solutions
2.14.4 Ono Pharmaceutical Anticancer Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 Ono Pharmaceutical Recent Developments and Future Plans
2.15 Pfizer
2.15.1 Pfizer Details
2.15.2 Pfizer Major Business
2.15.3 Pfizer Anticancer Drugs Product and Solutions
2.15.4 Pfizer Anticancer Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 Pfizer Recent Developments and Future Plans
2.16 GSK
2.16.1 GSK Details
2.16.2 GSK Major Business
2.16.3 GSK Anticancer Drugs Product and Solutions
2.16.4 GSK Anticancer Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.16.5 GSK Recent Developments and Future Plans
2.17 Exelixis
2.17.1 Exelixis Details
2.17.2 Exelixis Major Business
2.17.3 Exelixis Anticancer Drugs Product and Solutions
2.17.4 Exelixis Anticancer Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.17.5 Exelixis Recent Developments and Future Plans
2.18 Regeneron
2.18.1 Regeneron Details
2.18.2 Regeneron Major Business
2.18.3 Regeneron Anticancer Drugs Product and Solutions
2.18.4 Regeneron Anticancer Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.18.5 Regeneron Recent Developments and Future Plans
2.19 Innovent
2.19.1 Innovent Details
2.19.2 Innovent Major Business
2.19.3 Innovent Anticancer Drugs Product and Solutions
2.19.4 Innovent Anticancer Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.19.5 Innovent Recent Developments and Future Plans
2.20 Hengrui Medicine
2.20.1 Hengrui Medicine Details
2.20.2 Hengrui Medicine Major Business
2.20.3 Hengrui Medicine Anticancer Drugs Product and Solutions
2.20.4 Hengrui Medicine Anticancer Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.20.5 Hengrui Medicine Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Anticancer Drugs Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Anticancer Drugs by Company Revenue
3.2.2 Top 3 Anticancer Drugs Players Market Share in 2024
3.2.3 Top 6 Anticancer Drugs Players Market Share in 2024
3.3 Anticancer Drugs Market: Overall Company Footprint Analysis
3.3.1 Anticancer Drugs Market: Region Footprint
3.3.2 Anticancer Drugs Market: Company Product Type Footprint
3.3.3 Anticancer Drugs Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Anticancer Drugs Consumption Value and Market Share by Type (2020-2025)
4.2 Global Anticancer Drugs Market Forecast by Type (2026-2031)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Anticancer Drugs Consumption Value Market Share by Application (2020-2025)
5.2 Global Anticancer Drugs Market Forecast by Application (2026-2031)
6 NORTH AMERICA
6.1 North America Anticancer Drugs Consumption Value by Type (2020-2031)
6.2 North America Anticancer Drugs Market Size by Application (2020-2031)
6.3 North America Anticancer Drugs Market Size by Country
6.3.1 North America Anticancer Drugs Consumption Value by Country (2020-2031)
6.3.2 United States Anticancer Drugs Market Size and Forecast (2020-2031)
6.3.3 Canada Anticancer Drugs Market Size and Forecast (2020-2031)
6.3.4 Mexico Anticancer Drugs Market Size and Forecast (2020-2031)
7 EUROPE
7.1 Europe Anticancer Drugs Consumption Value by Type (2020-2031)
7.2 Europe Anticancer Drugs Consumption Value by Application (2020-2031)
7.3 Europe Anticancer Drugs Market Size by Country
7.3.1 Europe Anticancer Drugs Consumption Value by Country (2020-2031)
7.3.2 Germany Anticancer Drugs Market Size and Forecast (2020-2031)
7.3.3 France Anticancer Drugs Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Anticancer Drugs Market Size and Forecast (2020-2031)
7.3.5 Russia Anticancer Drugs Market Size and Forecast (2020-2031)
7.3.6 Italy Anticancer Drugs Market Size and Forecast (2020-2031)
8 ASIA-PACIFIC
8.1 Asia-Pacific Anticancer Drugs Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Anticancer Drugs Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Anticancer Drugs Market Size by Region
8.3.1 Asia-Pacific Anticancer Drugs Consumption Value by Region (2020-2031)
8.3.2 China Anticancer Drugs Market Size and Forecast (2020-2031)
8.3.3 Japan Anticancer Drugs Market Size and Forecast (2020-2031)
8.3.4 South Korea Anticancer Drugs Market Size and Forecast (2020-2031)
8.3.5 India Anticancer Drugs Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Anticancer Drugs Market Size and Forecast (2020-2031)
8.3.7 Australia Anticancer Drugs Market Size and Forecast (2020-2031)
9 SOUTH AMERICA
9.1 South America Anticancer Drugs Consumption Value by Type (2020-2031)
9.2 South America Anticancer Drugs Consumption Value by Application (2020-2031)
9.3 South America Anticancer Drugs Market Size by Country
9.3.1 South America Anticancer Drugs Consumption Value by Country (2020-2031)
9.3.2 Brazil Anticancer Drugs Market Size and Forecast (2020-2031)
9.3.3 Argentina Anticancer Drugs Market Size and Forecast (2020-2031)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Anticancer Drugs Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Anticancer Drugs Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Anticancer Drugs Market Size by Country
10.3.1 Middle East & Africa Anticancer Drugs Consumption Value by Country (2020-2031)
10.3.2 Turkey Anticancer Drugs Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Anticancer Drugs Market Size and Forecast (2020-2031)
10.3.4 UAE Anticancer Drugs Market Size and Forecast (2020-2031)
11 MARKET DYNAMICS
11.1 Anticancer Drugs Market Drivers
11.2 Anticancer Drugs Market Restraints
11.3 Anticancer Drugs Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Anticancer Drugs Industry Chain
12.2 Anticancer Drugs Upstream Analysis
12.3 Anticancer Drugs Midstream Analysis
12.4 Anticancer Drugs Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Anticancer Drugs Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Anticancer Drugs Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Global Anticancer Drugs Consumption Value by Region (2020-2025) & (USD Million)
Table 4. Global Anticancer Drugs Consumption Value by Region (2026-2031) & (USD Million)
Table 5. AbbVie Company Information, Head Office, and Major Competitors
Table 6. AbbVie Major Business
Table 7. AbbVie Anticancer Drugs Product and Solutions
Table 8. AbbVie Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 9. AbbVie Recent Developments and Future Plans
Table 10. Johnson & Johnson Company Information, Head Office, and Major Competitors
Table 11. Johnson & Johnson Major Business
Table 12. Johnson & Johnson Anticancer Drugs Product and Solutions
Table 13. Johnson & Johnson Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 14. Johnson & Johnson Recent Developments and Future Plans
Table 15. Novartis Company Information, Head Office, and Major Competitors
Table 16. Novartis Major Business
Table 17. Novartis Anticancer Drugs Product and Solutions
Table 18. Novartis Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 19. Gilead Sciences Company Information, Head Office, and Major Competitors
Table 20. Gilead Sciences Major Business
Table 21. Gilead Sciences Anticancer Drugs Product and Solutions
Table 22. Gilead Sciences Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 23. Gilead Sciences Recent Developments and Future Plans
Table 24. Roche Company Information, Head Office, and Major Competitors
Table 25. Roche Major Business
Table 26. Roche Anticancer Drugs Product and Solutions
Table 27. Roche Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 28. Roche Recent Developments and Future Plans
Table 29. Bristol-Myers Squibb Company Information, Head Office, and Major Competitors
Table 30. Bristol-Myers Squibb Major Business
Table 31. Bristol-Myers Squibb Anticancer Drugs Product and Solutions
Table 32. Bristol-Myers Squibb Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 33. Bristol-Myers Squibb Recent Developments and Future Plans
Table 34. Amgen Company Information, Head Office, and Major Competitors
Table 35. Amgen Major Business
Table 36. Amgen Anticancer Drugs Product and Solutions
Table 37. Amgen Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 38. Amgen Recent Developments and Future Plans
Table 39. AstraZeneca Company Information, Head Office, and Major Competitors
Table 40. AstraZeneca Major Business
Table 41. AstraZeneca Anticancer Drugs Product and Solutions
Table 42. AstraZeneca Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 43. AstraZeneca Recent Developments and Future Plans
Table 44. Merck & Co Company Information, Head Office, and Major Competitors
Table 45. Merck & Co Major Business
Table 46. Merck & Co Anticancer Drugs Product and Solutions
Table 47. Merck & Co Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 48. Merck & Co Recent Developments and Future Plans
Table 49. Takeda Company Information, Head Office, and Major Competitors
Table 50. Takeda Major Business
Table 51. Takeda Anticancer Drugs Product and Solutions
Table 52. Takeda Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 53. Takeda Recent Developments and Future Plans
Table 54. Merck KGaA Company Information, Head Office, and Major Competitors
Table 55. Merck KGaA Major Business
Table 56. Merck KGaA Anticancer Drugs Product and Solutions
Table 57. Merck KGaA Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 58. Merck KGaA Recent Developments and Future Plans
Table 59. Seagen Company Information, Head Office, and Major Competitors
Table 60. Seagen Major Business
Table 61. Seagen Anticancer Drugs Product and Solutions
Table 62. Seagen Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 63. Seagen Recent Developments and Future Plans
Table 64. Eli Lilly Company Information, Head Office, and Major Competitors
Table 65. Eli Lilly Major Business
Table 66. Eli Lilly Anticancer Drugs Product and Solutions
Table 67. Eli Lilly Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 68. Eli Lilly Recent Developments and Future Plans
Table 69. Ono Pharmaceutical Company Information, Head Office, and Major Competitors
Table 70. Ono Pharmaceutical Major Business
Table 71. Ono Pharmaceutical Anticancer Drugs Product and Solutions
Table 72. Ono Pharmaceutical Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 73. Ono Pharmaceutical Recent Developments and Future Plans
Table 74. Pfizer Company Information, Head Office, and Major Competitors
Table 75. Pfizer Major Business
Table 76. Pfizer Anticancer Drugs Product and Solutions
Table 77. Pfizer Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 78. Pfizer Recent Developments and Future Plans
Table 79. GSK Company Information, Head Office, and Major Competitors
Table 80. GSK Major Business
Table 81. GSK Anticancer Drugs Product and Solutions
Table 82. GSK Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 83. GSK Recent Developments and Future Plans
Table 84. Exelixis Company Information, Head Office, and Major Competitors
Table 85. Exelixis Major Business
Table 86. Exelixis Anticancer Drugs Product and Solutions
Table 87. Exelixis Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 88. Exelixis Recent Developments and Future Plans
Table 89. Regeneron Company Information, Head Office, and Major Competitors
Table 90. Regeneron Major Business
Table 91. Regeneron Anticancer Drugs Product and Solutions
Table 92. Regeneron Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 93. Regeneron Recent Developments and Future Plans
Table 94. Innovent Company Information, Head Office, and Major Competitors
Table 95. Innovent Major Business
Table 96. Innovent Anticancer Drugs Product and Solutions
Table 97. Innovent Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 98. Innovent Recent Developments and Future Plans
Table 99. Hengrui Medicine Company Information, Head Office, and Major Competitors
Table 100. Hengrui Medicine Major Business
Table 101. Hengrui Medicine Anticancer Drugs Product and Solutions
Table 102. Hengrui Medicine Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 103. Hengrui Medicine Recent Developments and Future Plans
Table 104. Global Anticancer Drugs Revenue (USD Million) by Players (2020-2025)
Table 105. Global Anticancer Drugs Revenue Share by Players (2020-2025)
Table 106. Breakdown of Anticancer Drugs by Company Type (Tier 1, Tier 2, and Tier 3)
Table 107. Market Position of Players in Anticancer Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 108. Head Office of Key Anticancer Drugs Players
Table 109. Anticancer Drugs Market: Company Product Type Footprint
Table 110. Anticancer Drugs Market: Company Product Application Footprint
Table 111. Anticancer Drugs New Market Entrants and Barriers to Market Entry
Table 112. Anticancer Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 113. Global Anticancer Drugs Consumption Value (USD Million) by Type (2020-2025)
Table 114. Global Anticancer Drugs Consumption Value Share by Type (2020-2025)
Table 115. Global Anticancer Drugs Consumption Value Forecast by Type (2026-2031)
Table 116. Global Anticancer Drugs Consumption Value by Application (2020-2025)
Table 117. Global Anticancer Drugs Consumption Value Forecast by Application (2026-2031)
Table 118. North America Anticancer Drugs Consumption Value by Type (2020-2025) & (USD Million)
Table 119. North America Anticancer Drugs Consumption Value by Type (2026-2031) & (USD Million)
Table 120. North America Anticancer Drugs Consumption Value by Application (2020-2025) & (USD Million)
Table 121. North America Anticancer Drugs Consumption Value by Application (2026-2031) & (USD Million)
Table 122. North America Anticancer Drugs Consumption Value by Country (2020-2025) & (USD Million)
Table 123. North America Anticancer Drugs Consumption Value by Country (2026-2031) & (USD Million)
Table 124. Europe Anticancer Drugs Consumption Value by Type (2020-2025) & (USD Million)
Table 125. Europe Anticancer Drugs Consumption Value by Type (2026-2031) & (USD Million)
Table 126. Europe Anticancer Drugs Consumption Value by Application (2020-2025) & (USD Million)
Table 127. Europe Anticancer Drugs Consumption Value by Application (2026-2031) & (USD Million)
Table 128. Europe Anticancer Drugs Consumption Value by Country (2020-2025) & (USD Million)
Table 129. Europe Anticancer Drugs Consumption Value by Country (2026-2031) & (USD Million)
Table 130. Asia-Pacific Anticancer Drugs Consumption Value by Type (2020-2025) & (USD Million)
Table 131. Asia-Pacific Anticancer Drugs Consumption Value by Type (2026-2031) & (USD Million)
Table 132. Asia-Pacific Anticancer Drugs Consumption Value by Application (2020-2025) & (USD Million)
Table 133. Asia-Pacific Anticancer Drugs Consumption Value by Application (2026-2031) & (USD Million)
Table 134. Asia-Pacific Anticancer Drugs Consumption Value by Region (2020-2025) & (USD Million)
Table 135. Asia-Pacific Anticancer Drugs Consumption Value by Region (2026-2031) & (USD Million)
Table 136. South America Anticancer Drugs Consumption Value by Type (2020-2025) & (USD Million)
Table 137. South America Anticancer Drugs Consumption Value by Type (2026-2031) & (USD Million)
Table 138. South America Anticancer Drugs Consumption Value by Application (2020-2025) & (USD Million)
Table 139. South America Anticancer Drugs Consumption Value by Application (2026-2031) & (USD Million)
Table 140. South America Anticancer Drugs Consumption Value by Country (2020-2025) & (USD Million)
Table 141. South America Anticancer Drugs Consumption Value by Country (2026-2031) & (USD Million)
Table 142. Middle East & Africa Anticancer Drugs Consumption Value by Type (2020-2025) & (USD Million)
Table 143. Middle East & Africa Anticancer Drugs Consumption Value by Type (2026-2031) & (USD Million)
Table 144. Middle East & Africa Anticancer Drugs Consumption Value by Application (2020-2025) & (USD Million)
Table 145. Middle East & Africa Anticancer Drugs Consumption Value by Application (2026-2031) & (USD Million)
Table 146. Middle East & Africa Anticancer Drugs Consumption Value by Country (2020-2025) & (USD Million)
Table 147. Middle East & Africa Anticancer Drugs Consumption Value by Country (2026-2031) & (USD Million)
Table 148. Global Key Players of Anticancer Drugs Upstream (Raw Materials)
Table 149. Global Anticancer Drugs Typical Customers
Table 1. Global Anticancer Drugs Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Anticancer Drugs Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Global Anticancer Drugs Consumption Value by Region (2020-2025) & (USD Million)
Table 4. Global Anticancer Drugs Consumption Value by Region (2026-2031) & (USD Million)
Table 5. AbbVie Company Information, Head Office, and Major Competitors
Table 6. AbbVie Major Business
Table 7. AbbVie Anticancer Drugs Product and Solutions
Table 8. AbbVie Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 9. AbbVie Recent Developments and Future Plans
Table 10. Johnson & Johnson Company Information, Head Office, and Major Competitors
Table 11. Johnson & Johnson Major Business
Table 12. Johnson & Johnson Anticancer Drugs Product and Solutions
Table 13. Johnson & Johnson Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 14. Johnson & Johnson Recent Developments and Future Plans
Table 15. Novartis Company Information, Head Office, and Major Competitors
Table 16. Novartis Major Business
Table 17. Novartis Anticancer Drugs Product and Solutions
Table 18. Novartis Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 19. Gilead Sciences Company Information, Head Office, and Major Competitors
Table 20. Gilead Sciences Major Business
Table 21. Gilead Sciences Anticancer Drugs Product and Solutions
Table 22. Gilead Sciences Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 23. Gilead Sciences Recent Developments and Future Plans
Table 24. Roche Company Information, Head Office, and Major Competitors
Table 25. Roche Major Business
Table 26. Roche Anticancer Drugs Product and Solutions
Table 27. Roche Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 28. Roche Recent Developments and Future Plans
Table 29. Bristol-Myers Squibb Company Information, Head Office, and Major Competitors
Table 30. Bristol-Myers Squibb Major Business
Table 31. Bristol-Myers Squibb Anticancer Drugs Product and Solutions
Table 32. Bristol-Myers Squibb Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 33. Bristol-Myers Squibb Recent Developments and Future Plans
Table 34. Amgen Company Information, Head Office, and Major Competitors
Table 35. Amgen Major Business
Table 36. Amgen Anticancer Drugs Product and Solutions
Table 37. Amgen Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 38. Amgen Recent Developments and Future Plans
Table 39. AstraZeneca Company Information, Head Office, and Major Competitors
Table 40. AstraZeneca Major Business
Table 41. AstraZeneca Anticancer Drugs Product and Solutions
Table 42. AstraZeneca Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 43. AstraZeneca Recent Developments and Future Plans
Table 44. Merck & Co Company Information, Head Office, and Major Competitors
Table 45. Merck & Co Major Business
Table 46. Merck & Co Anticancer Drugs Product and Solutions
Table 47. Merck & Co Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 48. Merck & Co Recent Developments and Future Plans
Table 49. Takeda Company Information, Head Office, and Major Competitors
Table 50. Takeda Major Business
Table 51. Takeda Anticancer Drugs Product and Solutions
Table 52. Takeda Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 53. Takeda Recent Developments and Future Plans
Table 54. Merck KGaA Company Information, Head Office, and Major Competitors
Table 55. Merck KGaA Major Business
Table 56. Merck KGaA Anticancer Drugs Product and Solutions
Table 57. Merck KGaA Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 58. Merck KGaA Recent Developments and Future Plans
Table 59. Seagen Company Information, Head Office, and Major Competitors
Table 60. Seagen Major Business
Table 61. Seagen Anticancer Drugs Product and Solutions
Table 62. Seagen Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 63. Seagen Recent Developments and Future Plans
Table 64. Eli Lilly Company Information, Head Office, and Major Competitors
Table 65. Eli Lilly Major Business
Table 66. Eli Lilly Anticancer Drugs Product and Solutions
Table 67. Eli Lilly Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 68. Eli Lilly Recent Developments and Future Plans
Table 69. Ono Pharmaceutical Company Information, Head Office, and Major Competitors
Table 70. Ono Pharmaceutical Major Business
Table 71. Ono Pharmaceutical Anticancer Drugs Product and Solutions
Table 72. Ono Pharmaceutical Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 73. Ono Pharmaceutical Recent Developments and Future Plans
Table 74. Pfizer Company Information, Head Office, and Major Competitors
Table 75. Pfizer Major Business
Table 76. Pfizer Anticancer Drugs Product and Solutions
Table 77. Pfizer Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 78. Pfizer Recent Developments and Future Plans
Table 79. GSK Company Information, Head Office, and Major Competitors
Table 80. GSK Major Business
Table 81. GSK Anticancer Drugs Product and Solutions
Table 82. GSK Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 83. GSK Recent Developments and Future Plans
Table 84. Exelixis Company Information, Head Office, and Major Competitors
Table 85. Exelixis Major Business
Table 86. Exelixis Anticancer Drugs Product and Solutions
Table 87. Exelixis Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 88. Exelixis Recent Developments and Future Plans
Table 89. Regeneron Company Information, Head Office, and Major Competitors
Table 90. Regeneron Major Business
Table 91. Regeneron Anticancer Drugs Product and Solutions
Table 92. Regeneron Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 93. Regeneron Recent Developments and Future Plans
Table 94. Innovent Company Information, Head Office, and Major Competitors
Table 95. Innovent Major Business
Table 96. Innovent Anticancer Drugs Product and Solutions
Table 97. Innovent Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 98. Innovent Recent Developments and Future Plans
Table 99. Hengrui Medicine Company Information, Head Office, and Major Competitors
Table 100. Hengrui Medicine Major Business
Table 101. Hengrui Medicine Anticancer Drugs Product and Solutions
Table 102. Hengrui Medicine Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 103. Hengrui Medicine Recent Developments and Future Plans
Table 104. Global Anticancer Drugs Revenue (USD Million) by Players (2020-2025)
Table 105. Global Anticancer Drugs Revenue Share by Players (2020-2025)
Table 106. Breakdown of Anticancer Drugs by Company Type (Tier 1, Tier 2, and Tier 3)
Table 107. Market Position of Players in Anticancer Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 108. Head Office of Key Anticancer Drugs Players
Table 109. Anticancer Drugs Market: Company Product Type Footprint
Table 110. Anticancer Drugs Market: Company Product Application Footprint
Table 111. Anticancer Drugs New Market Entrants and Barriers to Market Entry
Table 112. Anticancer Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 113. Global Anticancer Drugs Consumption Value (USD Million) by Type (2020-2025)
Table 114. Global Anticancer Drugs Consumption Value Share by Type (2020-2025)
Table 115. Global Anticancer Drugs Consumption Value Forecast by Type (2026-2031)
Table 116. Global Anticancer Drugs Consumption Value by Application (2020-2025)
Table 117. Global Anticancer Drugs Consumption Value Forecast by Application (2026-2031)
Table 118. North America Anticancer Drugs Consumption Value by Type (2020-2025) & (USD Million)
Table 119. North America Anticancer Drugs Consumption Value by Type (2026-2031) & (USD Million)
Table 120. North America Anticancer Drugs Consumption Value by Application (2020-2025) & (USD Million)
Table 121. North America Anticancer Drugs Consumption Value by Application (2026-2031) & (USD Million)
Table 122. North America Anticancer Drugs Consumption Value by Country (2020-2025) & (USD Million)
Table 123. North America Anticancer Drugs Consumption Value by Country (2026-2031) & (USD Million)
Table 124. Europe Anticancer Drugs Consumption Value by Type (2020-2025) & (USD Million)
Table 125. Europe Anticancer Drugs Consumption Value by Type (2026-2031) & (USD Million)
Table 126. Europe Anticancer Drugs Consumption Value by Application (2020-2025) & (USD Million)
Table 127. Europe Anticancer Drugs Consumption Value by Application (2026-2031) & (USD Million)
Table 128. Europe Anticancer Drugs Consumption Value by Country (2020-2025) & (USD Million)
Table 129. Europe Anticancer Drugs Consumption Value by Country (2026-2031) & (USD Million)
Table 130. Asia-Pacific Anticancer Drugs Consumption Value by Type (2020-2025) & (USD Million)
Table 131. Asia-Pacific Anticancer Drugs Consumption Value by Type (2026-2031) & (USD Million)
Table 132. Asia-Pacific Anticancer Drugs Consumption Value by Application (2020-2025) & (USD Million)
Table 133. Asia-Pacific Anticancer Drugs Consumption Value by Application (2026-2031) & (USD Million)
Table 134. Asia-Pacific Anticancer Drugs Consumption Value by Region (2020-2025) & (USD Million)
Table 135. Asia-Pacific Anticancer Drugs Consumption Value by Region (2026-2031) & (USD Million)
Table 136. South America Anticancer Drugs Consumption Value by Type (2020-2025) & (USD Million)
Table 137. South America Anticancer Drugs Consumption Value by Type (2026-2031) & (USD Million)
Table 138. South America Anticancer Drugs Consumption Value by Application (2020-2025) & (USD Million)
Table 139. South America Anticancer Drugs Consumption Value by Application (2026-2031) & (USD Million)
Table 140. South America Anticancer Drugs Consumption Value by Country (2020-2025) & (USD Million)
Table 141. South America Anticancer Drugs Consumption Value by Country (2026-2031) & (USD Million)
Table 142. Middle East & Africa Anticancer Drugs Consumption Value by Type (2020-2025) & (USD Million)
Table 143. Middle East & Africa Anticancer Drugs Consumption Value by Type (2026-2031) & (USD Million)
Table 144. Middle East & Africa Anticancer Drugs Consumption Value by Application (2020-2025) & (USD Million)
Table 145. Middle East & Africa Anticancer Drugs Consumption Value by Application (2026-2031) & (USD Million)
Table 146. Middle East & Africa Anticancer Drugs Consumption Value by Country (2020-2025) & (USD Million)
Table 147. Middle East & Africa Anticancer Drugs Consumption Value by Country (2026-2031) & (USD Million)
Table 148. Global Key Players of Anticancer Drugs Upstream (Raw Materials)
Table 149. Global Anticancer Drugs Typical Customers
LIST OF FIGURES
Figure 1. Anticancer Drugs Picture
Figure 2. Global Anticancer Drugs Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Anticancer Drugs Consumption Value Market Share by Type in 2024
Figure 4. Cancer Immunotherapy
Figure 5. Targeted Therapy
Figure 6. Chemotherapy
Figure 7. Other
Figure 8. Global Anticancer Drugs Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 9. Anticancer Drugs Consumption Value Market Share by Application in 2024
Figure 10. Lung Cancer Picture
Figure 11. Breast Cancer Picture
Figure 12. Prostate Cancer Picture
Figure 13. Blood-related Cancer Picture
Figure 14. Other Picture
Figure 15. Global Anticancer Drugs Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 16. Global Anticancer Drugs Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 17. Global Market Anticancer Drugs Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
Figure 18. Global Anticancer Drugs Consumption Value Market Share by Region (2020-2031)
Figure 19. Global Anticancer Drugs Consumption Value Market Share by Region in 2024
Figure 20. North America Anticancer Drugs Consumption Value (2020-2031) & (USD Million)
Figure 21. Europe Anticancer Drugs Consumption Value (2020-2031) & (USD Million)
Figure 22. Asia-Pacific Anticancer Drugs Consumption Value (2020-2031) & (USD Million)
Figure 23. South America Anticancer Drugs Consumption Value (2020-2031) & (USD Million)
Figure 24. Middle East & Africa Anticancer Drugs Consumption Value (2020-2031) & (USD Million)
Figure 25. Company Three Recent Developments and Future Plans
Figure 26. Global Anticancer Drugs Revenue Share by Players in 2024
Figure 27. Anticancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
Figure 28. Market Share of Anticancer Drugs by Player Revenue in 2024
Figure 29. Top 3 Anticancer Drugs Players Market Share in 2024
Figure 30. Top 6 Anticancer Drugs Players Market Share in 2024
Figure 31. Global Anticancer Drugs Consumption Value Share by Type (2020-2025)
Figure 32. Global Anticancer Drugs Market Share Forecast by Type (2026-2031)
Figure 33. Global Anticancer Drugs Consumption Value Share by Application (2020-2025)
Figure 34. Global Anticancer Drugs Market Share Forecast by Application (2026-2031)
Figure 35. North America Anticancer Drugs Consumption Value Market Share by Type (2020-2031)
Figure 36. North America Anticancer Drugs Consumption Value Market Share by Application (2020-2031)
Figure 37. North America Anticancer Drugs Consumption Value Market Share by Country (2020-2031)
Figure 38. United States Anticancer Drugs Consumption Value (2020-2031) & (USD Million)
Figure 39. Canada Anticancer Drugs Consumption Value (2020-2031) & (USD Million)
Figure 40. Mexico Anticancer Drugs Consumption Value (2020-2031) & (USD Million)
Figure 41. Europe Anticancer Drugs Consumption Value Market Share by Type (2020-2031)
Figure 42. Europe Anticancer Drugs Consumption Value Market Share by Application (2020-2031)
Figure 43. Europe Anticancer Drugs Consumption Value Market Share by Country (2020-2031)
Figure 44. Germany Anticancer Drugs Consumption Value (2020-2031) & (USD Million)
Figure 45. France Anticancer Drugs Consumption Value (2020-2031) & (USD Million)
Figure 46. United Kingdom Anticancer Drugs Consumption Value (2020-2031) & (USD Million)
Figure 47. Russia Anticancer Drugs Consumption Value (2020-2031) & (USD Million)
Figure 48. Italy Anticancer Drugs Consumption Value (2020-2031) & (USD Million)
Figure 49. Asia-Pacific Anticancer Drugs Consumption Value Market Share by Type (2020-2031)
Figure 50. Asia-Pacific Anticancer Drugs Consumption Value Market Share by Application (2020-2031)
Figure 51. Asia-Pacific Anticancer Drugs Consumption Value Market Share by Region (2020-2031)
Figure 52. China Anticancer Drugs Consumption Value (2020-2031) & (USD Million)
Figure 53. Japan Anticancer Drugs Consumption Value (2020-2031) & (USD Million)
Figure 54. South Korea Anticancer Drugs Consumption Value (2020-2031) & (USD Million)
Figure 55. India Anticancer Drugs Consumption Value (2020-2031) & (USD Million)
Figure 56. Southeast Asia Anticancer Drugs Consumption Value (2020-2031) & (USD Million)
Figure 57. Australia Anticancer Drugs Consumption Value (2020-2031) & (USD Million)
Figure 58. South America Anticancer Drugs Consumption Value Market Share by Type (2020-2031)
Figure 59. South America Anticancer Drugs Consumption Value Market Share by Application (2020-2031)
Figure 60. South America Anticancer Drugs Consumption Value Market Share by Country (2020-2031)
Figure 61. Brazil Anticancer Drugs Consumption Value (2020-2031) & (USD Million)
Figure 62. Argentina Anticancer Drugs Consumption Value (2020-2031) & (USD Million)
Figure 63. Middle East & Africa Anticancer Drugs Consumption Value Market Share by Type (2020-2031)
Figure 64. Middle East & Africa Anticancer Drugs Consumption Value Market Share by Application (2020-2031)
Figure 65. Middle East & Africa Anticancer Drugs Consumption Value Market Share by Country (2020-2031)
Figure 66. Turkey Anticancer Drugs Consumption Value (2020-2031) & (USD Million)
Figure 67. Saudi Arabia Anticancer Drugs Consumption Value (2020-2031) & (USD Million)
Figure 68. UAE Anticancer Drugs Consumption Value (2020-2031) & (USD Million)
Figure 69. Anticancer Drugs Market Drivers
Figure 70. Anticancer Drugs Market Restraints
Figure 71. Anticancer Drugs Market Trends
Figure 72. Porters Five Forces Analysis
Figure 73. Anticancer Drugs Industrial Chain
Figure 74. Methodology
Figure 75. Research Process and Data Source
Figure 1. Anticancer Drugs Picture
Figure 2. Global Anticancer Drugs Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Anticancer Drugs Consumption Value Market Share by Type in 2024
Figure 4. Cancer Immunotherapy
Figure 5. Targeted Therapy
Figure 6. Chemotherapy
Figure 7. Other
Figure 8. Global Anticancer Drugs Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 9. Anticancer Drugs Consumption Value Market Share by Application in 2024
Figure 10. Lung Cancer Picture
Figure 11. Breast Cancer Picture
Figure 12. Prostate Cancer Picture
Figure 13. Blood-related Cancer Picture
Figure 14. Other Picture
Figure 15. Global Anticancer Drugs Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 16. Global Anticancer Drugs Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 17. Global Market Anticancer Drugs Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
Figure 18. Global Anticancer Drugs Consumption Value Market Share by Region (2020-2031)
Figure 19. Global Anticancer Drugs Consumption Value Market Share by Region in 2024
Figure 20. North America Anticancer Drugs Consumption Value (2020-2031) & (USD Million)
Figure 21. Europe Anticancer Drugs Consumption Value (2020-2031) & (USD Million)
Figure 22. Asia-Pacific Anticancer Drugs Consumption Value (2020-2031) & (USD Million)
Figure 23. South America Anticancer Drugs Consumption Value (2020-2031) & (USD Million)
Figure 24. Middle East & Africa Anticancer Drugs Consumption Value (2020-2031) & (USD Million)
Figure 25. Company Three Recent Developments and Future Plans
Figure 26. Global Anticancer Drugs Revenue Share by Players in 2024
Figure 27. Anticancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
Figure 28. Market Share of Anticancer Drugs by Player Revenue in 2024
Figure 29. Top 3 Anticancer Drugs Players Market Share in 2024
Figure 30. Top 6 Anticancer Drugs Players Market Share in 2024
Figure 31. Global Anticancer Drugs Consumption Value Share by Type (2020-2025)
Figure 32. Global Anticancer Drugs Market Share Forecast by Type (2026-2031)
Figure 33. Global Anticancer Drugs Consumption Value Share by Application (2020-2025)
Figure 34. Global Anticancer Drugs Market Share Forecast by Application (2026-2031)
Figure 35. North America Anticancer Drugs Consumption Value Market Share by Type (2020-2031)
Figure 36. North America Anticancer Drugs Consumption Value Market Share by Application (2020-2031)
Figure 37. North America Anticancer Drugs Consumption Value Market Share by Country (2020-2031)
Figure 38. United States Anticancer Drugs Consumption Value (2020-2031) & (USD Million)
Figure 39. Canada Anticancer Drugs Consumption Value (2020-2031) & (USD Million)
Figure 40. Mexico Anticancer Drugs Consumption Value (2020-2031) & (USD Million)
Figure 41. Europe Anticancer Drugs Consumption Value Market Share by Type (2020-2031)
Figure 42. Europe Anticancer Drugs Consumption Value Market Share by Application (2020-2031)
Figure 43. Europe Anticancer Drugs Consumption Value Market Share by Country (2020-2031)
Figure 44. Germany Anticancer Drugs Consumption Value (2020-2031) & (USD Million)
Figure 45. France Anticancer Drugs Consumption Value (2020-2031) & (USD Million)
Figure 46. United Kingdom Anticancer Drugs Consumption Value (2020-2031) & (USD Million)
Figure 47. Russia Anticancer Drugs Consumption Value (2020-2031) & (USD Million)
Figure 48. Italy Anticancer Drugs Consumption Value (2020-2031) & (USD Million)
Figure 49. Asia-Pacific Anticancer Drugs Consumption Value Market Share by Type (2020-2031)
Figure 50. Asia-Pacific Anticancer Drugs Consumption Value Market Share by Application (2020-2031)
Figure 51. Asia-Pacific Anticancer Drugs Consumption Value Market Share by Region (2020-2031)
Figure 52. China Anticancer Drugs Consumption Value (2020-2031) & (USD Million)
Figure 53. Japan Anticancer Drugs Consumption Value (2020-2031) & (USD Million)
Figure 54. South Korea Anticancer Drugs Consumption Value (2020-2031) & (USD Million)
Figure 55. India Anticancer Drugs Consumption Value (2020-2031) & (USD Million)
Figure 56. Southeast Asia Anticancer Drugs Consumption Value (2020-2031) & (USD Million)
Figure 57. Australia Anticancer Drugs Consumption Value (2020-2031) & (USD Million)
Figure 58. South America Anticancer Drugs Consumption Value Market Share by Type (2020-2031)
Figure 59. South America Anticancer Drugs Consumption Value Market Share by Application (2020-2031)
Figure 60. South America Anticancer Drugs Consumption Value Market Share by Country (2020-2031)
Figure 61. Brazil Anticancer Drugs Consumption Value (2020-2031) & (USD Million)
Figure 62. Argentina Anticancer Drugs Consumption Value (2020-2031) & (USD Million)
Figure 63. Middle East & Africa Anticancer Drugs Consumption Value Market Share by Type (2020-2031)
Figure 64. Middle East & Africa Anticancer Drugs Consumption Value Market Share by Application (2020-2031)
Figure 65. Middle East & Africa Anticancer Drugs Consumption Value Market Share by Country (2020-2031)
Figure 66. Turkey Anticancer Drugs Consumption Value (2020-2031) & (USD Million)
Figure 67. Saudi Arabia Anticancer Drugs Consumption Value (2020-2031) & (USD Million)
Figure 68. UAE Anticancer Drugs Consumption Value (2020-2031) & (USD Million)
Figure 69. Anticancer Drugs Market Drivers
Figure 70. Anticancer Drugs Market Restraints
Figure 71. Anticancer Drugs Market Trends
Figure 72. Porters Five Forces Analysis
Figure 73. Anticancer Drugs Industrial Chain
Figure 74. Methodology
Figure 75. Research Process and Data Source
